AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1676306
Drug: Indomethacin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75 mg b.d.)
Trial: 6357207
Drug: Suprofen 100
RxNorm normalized name: Suprofen
DrugBank: Suprofen (DB00870)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suprofen 100 mg + APAP 650 mg
Trial: 31269506
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA, 3.0 g/day)
Trial: 31269506
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (DHA, 1.4 g/day)
Trial: 22073579
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of long acting beta2 agonist (LABA) and inhaled corticosteroids (ICS)
Trial: 11908552
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (Neoral-Sandimmun, 3 mg/kg/day)
Trial: 10839074
Drug: Paracetamol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (30 to 50 mg/kg loading dose, followed by 70 to 100 mg/kg/24 hours) plus intramuscular fentanyl citrate (1 microgram/kg)
Trial: 8567509
Drug: 8% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% glucose solution with [U‐13C]glucose tracer
Trial: 2138049
Drug: Cilazapril (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril (1.25 to 5.0 mg/day, single dose)
Trial: 3178924
Drug: Midazolam 7.5
RxNorm normalized name: midazolam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 7.5 mg
Trial: 1535490
Drug: Oxazepam 25
RxNorm normalized name: Oxazepam 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 25 mg
Trial: 25238912
Drug: Nut group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nut group (30 g/d of mixed nuts for 6 weeks)
Trial: 11774098
Drug: Immunosuppressive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive therapy with prednisone and cyclophosphamide (n = 18)
Trial: 1837974
Drug: Anti‐inflammatory and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti‐inflammatory and anti‐fibrinolytic agents
Trial: 16356431
Drug: Extra fluids
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra fluids (intravenous fluid supplementation for 8 hours and oral supplementation for the duration of phototherapy)
Trial: 9449498
Drug: Subcutaneous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous epinephrine (0.01 ml/kg, maximum 0.3 ml [0.3 mg])
Trial: 9449498
Drug: Intramuscular epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular epinephrine (0.3 mg from an autoinjector)
Trial: 10150837
Drug: Antimetabolites as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimetabolites as pharmacologic modulators of wound healing in conjunction with argon laser suture lysis and small‐incision phacoemulsification techniques
Trial: 619949
Drug: Aluminium hydroxide
RxNorm normalized name: Aluminium hydroxide
DrugBank: Aluminum hydroxide (DB06723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminium hydroxide and glycopyrrhonium (combination)
Trial: 619949
Drug: Ethanol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.5 g/kg in 10% solution or 0.8 g/kg in 20% solution)
Trial: 21704306
Drug: Transdiagnostic cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdiagnostic cognitive behaviour therapy for eating disorders (CBT‐E)
Trial: 14551476
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (n = 202)
Trial: 8792892
Drug: Morphine with
RxNorm normalized name: opium alkaloids with morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine with droperidol (10mg droperidol/60 mg morphine)
Trial: 1599353
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of sustained-release pseudoephedrine taken twice daily
Trial: 7973107
Drug: Nebulised salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised salbutamol (5 mg)
Trial: 6229262
Drug: Nebulised ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised ipratropium (0.5 mg)
Trial: 6229262
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nebulised salbutamol and ipratropium
Trial: 29905663
Drug: Cognitive Processing
RxNorm normalized name: Allogeneic processed thymus tissue
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Processing Therapy (CPT) for MST-related PTSD
Trial: 24096258
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (375 ml, 41 g of alcohol)
Trial: 22584638
Drug: Rocuronium (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.9 mg/kg)
Trial: 27757709
Drug: Endothelin receptor
RxNorm normalized name: Endothelin receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelin receptor antagonists
Trial: 7924782
Drug: Alanine infusion
RxNorm normalized name: Alanine
DrugBank: Alanine (DB00160)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alanine infusion
Trial: 3172783
Drug: 0.56 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.56 g/kg ethanol
Trial: 27805026
Drug: AERAS-402 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AERAS-402 vaccine
Trial: 24889937
Drug: Combination budesonide/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination budesonide/formoterol inhaler as maintenance and reliever therapy ('SMART') regimen
Trial: 23110481
Drug: Ablative fractional
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ablative fractional carbon dioxide laser treatment at pulse durations of 500, 1,000, 1,500, and 1,800 μs.
Trial: 20488910
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg metformin three times a day for 4.3 years
Trial: 9280994
Drug: Propofol in
RxNorm normalized name: propofol Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol in continuous infusion with O2 and air (group III)
Trial: 1587065
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg losartan
Trial: 25537204
Drug: Gene therapy
RxNorm normalized name: E1A gene therapy
DrugBank: RGG0853 (DB18669)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene therapy for RPE65-LCA
Trial: 18544723
Drug: H. perforatum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. perforatum (St John's wort) 300 mg standardized to 0.3% hypericin, taken 3 times daily for 8 weeks
Trial: 18544723
Drug: Placebo, matched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, matched to H. perforatum, taken 3 times daily for 8 weeks
Trial: 15809508
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate (750-3,000 mg/day)
Trial: 15809508
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1,500-9,000 mg/day)
Trial: 10781212
Drug: Pentoxifylline 800
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline 800 mg three times a day
Trial: 9114906
Drug: Budesonide inhaled
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide inhaled from a Turbuhaler (1 mg)
Trial: 27501616
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 30 mL (Gr. B)
Trial: 27501616
Drug: Mixture of
RxNorm normalized name: OCTADECANOL (MIXTURE OF ISOMERS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixture of 0.5% bupivacaine 20 mL and 2% lidocaine 10 mL (Gr. BL)
Trial: 24671522
Drug: Plain aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain aspirin 100 mg od
Trial: 22571201
Drug: Lenalidomide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide (10 mg per day, range 5 to 15)
Trial: 8770849
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg r‐ProUK over 90 minutes
Trial: 8770849
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg r‐ProUK over 60 minutes (primed with recombinant urokinase)
Trial: 8770849
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg r‐ProUK over 90 minutes (primed with recombinant urokinase)
Trial: 2202709
Drug: Metronidazole 800
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole 800 mg
Trial: 6999618
Drug: Thiamphenicol (TAP)
RxNorm normalized name: thiamphenicol
DrugBank: Thiamphenicol (DB08621)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiamphenicol (TAP) 1.5 g daily for 14 days
Trial: 6999618
Drug: Trimethoprim-sulfamethoxazole (TMP-SMZ)
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (TMP-SMZ) 0.48 g TMP and 2.4 g SMZ daily for 14 days
Trial: 21394639
Drug: N-acetyl-cysteine (NAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl-cysteine (NAC) 600 mg PO
Trial: 17210881
Drug: Alteplase plus
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alteplase plus heparin sodium
Trial: 11589932
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (perindopril plus indapamide)
Trial: 12953850
Drug: Single-drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-drug therapy (perindopril alone)
Trial: 9751239
Drug: Niaspan 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niaspan 1.5 g at bedtime
Trial: 9751239
Drug: Plain niacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain niacin 1.5 g/d after 8 weeks
Trial: 17534379
Drug: Physostigmine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (1.0 mg/h)
Trial: 11403977
Drug: Buserelin treatment
RxNorm normalized name: buserelin
DrugBank: Buserelin (DB06719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin treatment
Trial: 29801011
Drug: Saline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (100 mL)
Trial: 29801011
Drug: Intravesical instillation
RxNorm normalized name: ADSTILADRIN Suspension for Intravesical Instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical instillation of gemcitabine (2 g in 100 mL of saline)
Trial: 27166360
Drug: Panobinostat 30
RxNorm normalized name: Panobinostat
DrugBank: Panobinostat (DB06603)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Panobinostat 30 mg orally 3 times weekly
Trial: 12432968
Drug: Dapsone 100
RxNorm normalized name: dapsone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 100 mg alone
Trial: 12432968
Drug: Dapsone 100
RxNorm normalized name: dapsone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 100 mg plus nizatidine 300 mg
Trial: 1849442
Drug: Single-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent chemotherapy (high-dose epirubicin)
Trial: 26891418
Drug: Early on-treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early on-treatment HCV RNA
Trial: 24950920
Drug: Low tidal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low tidal volume with PEEP (tidal volume = 6 mL/kg, rate = 18/minute, PEEP = 5 cm H(2)O)
Trial: 24950920
Drug: Conventional group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional group (tidal volume = 10 mL/kg, rate = 12/minute, PEEP = 0 cm H(2)O)
Trial: 17991646
Drug: Low-glucose solutions
RxNorm normalized name: calcium chloride / glucose / lactate / magnesium chloride / sodium chloride Intraperitoneal Solution [Dianeal Low Calcium 1.5]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-glucose solutions
Trial: 17991646
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and BG AUCs
Trial: 14733451
Drug: Intramuscular haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular haloperidol (7.5 mg)
Trial: 15231557
Drug: Intramuscular lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular lorazepam (4 mg)
Trial: 10921707
Drug: Heparin-bonded circuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded circuits
Trial: 11334193
Drug: Non-heparin-bonded circuits
RxNorm normalized name: SKIN BOND NON-FLAMMABLE CEMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-heparin-bonded circuits
Trial: 1277740
Drug: Single bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single bolus injection of methylglucamine iodipamide
Trial: 1277740
Drug: Both methods
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both methods (infusion and single bolus)
Trial: 25636814
Drug: WBVT +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WBVT + L-citrulline
Trial: 25636814
Drug: All interventions
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All interventions (WBVT, L-citrulline, WBVT + L-citrulline)
Trial: 16835031
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (gentle rubbing, stroking, passive movements of the limbs) performed by professionals until the infant is 8 months old
Trial: 15577227
Drug: Ninjin-to (6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ninjin-to (6.0 g, single oral administration)
Trial: 3087617
Drug: Doxorubicin (DOX)
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxorubicin (DOX) at 60 mg/m2, Ifosfamide (IFF) at 7500 mg/m2, Dacarbazine (DTIC) at 900 mg/m2 by continuous infusion over 72 hours
Trial: 3087617
Drug: Dacarbazine (DTIC)
RxNorm normalized name: Dacarbazine
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dacarbazine (DTIC) by continuous infusion
Trial: 31943737
Drug: Treatment assignment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment assignment with a biomarker measurement
Trial: 31943737
Drug: Time-dependent logistic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-dependent logistic model for treatment response
Trial: 29546305
Drug: Daily nutritional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily nutritional dose of antioxidant supplement (120 mg vitamin C, 6 mg β-carotene, 30 mg vitamin E, 100 μg Se, 20 mg Zn)
Trial: 21438929
Drug: Baseline CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline CSF L‐PGDS
Trial: 21438929
Drug: Change of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Change of CSF L‐PGDS after weight loss
Trial: 17967218
Drug: Aquacultured salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aquacultured salmon (250 g daily for 4 weeks providing 5 mug AST/g salmon flesh)
Trial: 17967218
Drug: Wild salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wild salmon (250 g daily for 4 weeks providing 5 mug AST/g salmon flesh)
Trial: 28948645
Drug: Doxycycline hyclate
RxNorm normalized name: Doxycycline Hyclate
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline hyclate (50 mg/d)
Trial: 23098480
Drug: Knowledge about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge about cervical cancer and HPV vaccine
Trial: 20335115
Drug: Basal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal treatment (Control group)
Trial: 2851179
Drug: Etoposide (single-agent)
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide (single-agent)
Trial: 16965639
Drug: Behavioral addiction
RxNorm normalized name: DRUGS USED IN ADDICTIVE DISORDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral addiction treatment with systematic reinforcement for goal attainment
Trial: 16965639
Drug: Behavioral addiction
RxNorm normalized name: DRUGS USED IN ADDICTIVE DISORDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral addiction treatment
Trial: 14633804
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of cinnamon daily
Trial: 14633804
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of cinnamon daily
Trial: 14633804
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g of cinnamon daily
Trial: 10627108
Drug: Aftercare treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aftercare treatment
Trial: 11255446
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg/d
Trial: 19055286
Drug: Routine massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine massage therapy in Tuina Science (Control)
Trial: 16649966
Drug: B vitamins
RxNorm normalized name: B-50 Hi Potency B Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B vitamins (5 mg of folic acid)
Trial: 12839261
Drug: 0.01% estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01% estradiol cream
Trial: 12839261
Drug: 15% glycolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% glycolic acid cream
Trial: 12839261
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 0.01% estradiol and 15% glycolic acid creams
Trial: 6720281
Drug: Indomethacin solution
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin solution (1% watery solution, 1 drop, 4 times a day for 2 weeks)
Trial: 6720281
Drug: Indomethacin solution
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin solution (local application during the first week post-surgery)
Trial: 31582360
Drug: High-titre anti-influenza
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-titre anti-influenza plasma (haemagglutination inhibition antibody titre ≥1:80)
Trial: 28811653
Drug: 50% of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% of daily energy consumed in the morning (BF group)
Trial: 28811653
Drug: 50% of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% of daily energy consumed in the evening (D group)
Trial: 26742068
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein (12 g) + normal fiber (2 g)
Trial: 26742068
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein (25 g) + high fiber (8 g)
Trial: 24958250
Drug: Electronic cigarette
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic cigarette (medium-strength nicotine concentration 11 mg/ml for 7 minutes)
Trial: 20539854
Drug: Cardiovascular risk
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardiovascular risk management package including education about risk factors and treatment with hydrochlorothiazide at 4 months for medium-risk patients.
Trial: 12120884
Drug: IFN‐alpha2a 9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha2a 9 million units 3x week for 6 months with HBV vaccine 20 microg given on 0, 1 and 2 months
Trial: 2669648
Drug: PGI2‐A (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGI2‐A (300 micrograms/L)
Trial: 1033056
Drug: Tablets taken
RxNorm normalized name: levonorgestrel Oral Tablet [Take Action]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets taken half-an-hour before breakfast
Trial: 1033056
Drug: Tablets taken
RxNorm normalized name: levonorgestrel Oral Tablet [Take Action]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets taken one hour before breakfast
Trial: 1287618
Drug: Cefaclor AF
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor AF (375 mg twice daily)
Trial: 1287618
Drug: Cefaclor (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (250 mg three times daily)